tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market
Holding IMNM?
Track your performance easily

Immunome (IMNM) Income Statement

194 Followers

Immunome Income Statement

Last quarter (Q3 2024), Immunome's total revenue was $2.91M, a decrease of -18.37% from the same quarter last year. In Q3, Immunome's net income was $-47.10M. See Immunome’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 10.13M$ 14.02M---$ 0.00
Cost of Revenue
------
Gross Profit
$ 10.13M$ 14.02M----
Operating Expense
$ 246.81M$ 42.75M$ 36.90M$ 25.20M$ 12.26M$ 10.35M
Operating Income
$ -317.48M$ -109.53M$ -36.90M$ -25.20M$ -12.26M$ -10.35M
Net Non Operating Interest Income Expense
$ 12.13M$ 2.72M$ 5.00K$ -10.00K$ -38.00K$ -96.00K
Other Income Expense
$ -80.78M$ -80.80M$ 622.00K$ -503.00K$ 5.50M-
Pretax Income
$ -180.40M$ -106.81M$ -36.90M$ -24.71M$ -17.80M$ -10.44M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -305.35M$ -106.81M$ -37.52M$ -24.71M$ -17.84M$ -10.44M
Basic EPS
$ -8.10$ -5.38$ -3.09$ -2.14$ -5.26$ -2.38
Diluted EPS
$ -8.10$ -5.38$ -3.09$ -2.14$ -5.26$ -2.38
Basic Average Shares
$ 214.48M$ 19.84M$ 12.13M$ 11.54M$ 3.39M$ 4.39M
Diluted Average Shares
$ 214.48M$ 19.84M$ 12.13M$ 11.54M$ 3.39M$ 4.39M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 246.81M$ 42.75M$ 36.90M$ 25.20M$ 12.26M$ 10.35M
Net Income From Continuing And Discontinued Operation
$ -305.35M$ -106.81M$ -36.90M$ -24.71M$ -17.84M$ -10.44M
Normalized Income
$ -69.50M----$ -10.44M
Interest Expense
-----$ 106.00K
EBIT
$ -205.53M$ -109.53M$ -36.90M$ -25.20M$ -17.80M$ -10.34M
EBITDA
$ -203.18M$ -108.76M$ -36.27M$ -24.45M$ -17.04M$ -9.72M
Currency in USD

Immunome Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis